VAP
Attacking the ‘Slime’ Could Improve VAP Care
Biofilms make it harder to treat ventilator-associated pneumonias.
SEPTEMBER 13, 2024
How Much Do We Know About Non-Ventilator HAP?
Better prevention of NV-HAP, the authors said, would improve patient care worldwide, while saving health systems ...
SEPTEMBER 13, 2024
FDA Approves Xacduro for HABP and VABP caused by Acinetobacter
Xacduro consists of sulbactam, a drug structurally related to penicillin, and durlobactam, which protects ...
MAY 23, 2023
Prior P. aeruginosa Infection Signals Risk for Community-Acquired Pneumonia
Patients with recent Pseudomonas aeruginosa infection or colonization are at higher risk for ...
DECEMBER 17, 2021
FDA Grants HABP/VABP Indication for Fetroja
The FDA approved a new indication for cefiderocol to treat adults with hospital-acquired bacterial pneumonia and ...
SEPTEMBER 29, 2020
VAP Rates Have Not Dropped
Contrary to CDC data, ventilator-associated pneumonia (VAP) rates in hospital ICUs have not declined significantly ...
NOVEMBER 16, 2016
